Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs
Go back to Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs| TONIX PHARM HLDG (NASDAQ: TNXP) | Delayed: 13.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.16 | 52 Week High | $7.95 | |||
| Open | $13.16 | 52 Week Low | $0.40 | |||
| Day High | $13.16 | P/E | N/A | |||
| Day Low | $13.16 | EPS | $-5.33 | |||
| Volume | 16 | |||||

